Similarly, a cohort study suggested that high to moderate levels of p16 expression in CRC sections may indicate that p16 plays a role in CRC carcinogenesis—though further research, with larger sample sizes, will be needed to confirm these findings [100]. The gene discussed is CDKN2A; the disease is colorectal carcinoma.